H. Ikeda

发表

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.

P. Coulie, T. Boon, H. Chambost, 1997, Immunity.

Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

M. Kizaki, Y. Ikeda, Y. Kawakami, 2001, British journal of haematology.

NOVEL APPROACH TO IMMUNOTHERAPY FOR EPITHELIAL CANCERS, BONE AND SOFT-TISSUE SARCOMAS

K. Hirata, T. Yamashita, N. Sato, 2004 .

Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes.

K. Hirata, A. Sasaki, N. Takahashi, 1999, Journal of immunology.

Carcinoma Recognized by of a Human Gastric Signet Ring Cell Identification of Natural Antigenic Peptides

K. Hirata, Shuji Takahashi, A. Sasaki, 1999 .

Identification of Human Autologous Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor

K. Ida, T. Yamashita, N. Sato, 2004, Cancer Research.

Identification of Human Cytotoxic T-Lymphocyte-Defined Osteosarcoma Gene That Encodes a Transcriptional Regulator, Papillomavirus Binding Factor

T. Yamashita, N. Sato, Y. Tamura, 2004 .

Natural Antigenic Peptides from Squamous Cell Carcinoma Recognized by Autologous HLA‐DR8–restricted CD4+ T Cells

A. Yamaguchi, N. Takahashi, N. Sato, 2002, Japanese journal of cancer research : Gann.

Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line

T. Yamashita, N. Sato, T. Tsukahara, 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

Improved generation of HLA class I/peptide tetramers.

T. Yamashita, S. Ichimiya, N. Sato, 2002, Journal of immunological methods.

Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-Aff24-recoverin tetramer

N. Sato, Y. Hirohashi, H. Sahara, 2002, Cancer Immunology, Immunotherapy.

Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer

M. Murai, J. Nakashima, M. Tachibana, 2004, International journal of cancer.

Antitumor immunity at work in a melanoma patient.

P. Coulie, R. Chiari, J. Baurain, 1999, Advances in cancer research.

Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.

N. Sato, H. Ikeda, K. Kikuchi, 1993, Cancer research.

Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells.

K. Kamiguchi, A. Sasaki, N. Sato, 2010, Experimental and molecular pathology.

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

K. Kamiguchi, N. Sato, Y. Hirohashi, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analysis of a Shared Pancreatic Cancer Antigen Recognized by an HLA-A*2601-Restricted Cytotoxic T-Lymphocyte Clone

K. Hirata, K. Kamiguchi, N. Sato, 2003, Pancreas.

Possible involvement of allogeneic antigens recognised by donor‐derived CD4+ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy

R. Yamazaki, Y. Ikeda, Y. Kawakami, 2006, British journal of haematology.

Crisscross CTL Induction by SYT-SSX Junction Peptide and Its HLA-A*2402 Anchor Substitute1

H. Yoshikawa, K. Ida, T. Yamashita, 2004, The Journal of Immunology.

[PRAME protein expressed in leukemia cells as a target molecule for immunotherapy].

H. Ikeda, M. Matsushita, H. Kawakami, 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology.

T‐Cell Receptor Gene Structures of HLA‐A26‐restricted Cytotoxic T Lymphocyte Lines against Human Autologous Pancreatic Adenocarcinoma

Shuji Takahashi, A. Sasaki, N. Sato, 1995, Japanese journal of cancer research : Gann.

Detection and Induction of CTLs Specific for SYT-SSX-Derived Peptides in HLA-A24+ Patients with Synovial Sarcoma1

T. Yamashita, N. Araki, S. Ichimiya, 2002, The Journal of Immunology.

Patients with Synovial Sarcoma + SYT-SSX-Derived Peptides in HLA-A 24 Detection and Induction of CTLs Specific for and Noriyuki

T. Yamashita, N. Araki, S. Ichimiya, 2002 .

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.

Q. Waisfisz, A. D’Andrea, M. Sasaki, 2003, Cancer research.

Human CD8 and CD4 T cell epitopes of epithelial cancer antigens

Yuki Nabeta, Shuji Takahashi, K. Kamiguchi, 2000, Cancer Chemotherapy and Pharmacology.

Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia‐derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption

Reinhard Ullmann, Crispin Miller, Crispin J. Miller, 2007, Genes, chromosomes & cancer.

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

T. Ohmura, K. Hirata, N. Sato, 2005, Clinical Cancer Research.

In vitro proliferation and the cytotoxic specificity of a cryopreserved cytotoxic T cell clone reacting against human autologous tumor cells.

K. Hirata, N. Sato, H. Ikeda, 1992, Journal of immunological methods.

Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells

M. Toyota, Hiromu Suzuki, Y. Sasaki, 2004, Oncogene.

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

Toshihiko Yamashita, Satoshi Kawaguchi, Tomohide Tsukahara, 2005, Journal of Translational Medicine.

Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies

R. Yamazaki, Y. Kawakami, H. Ikeda, 2003, Leukemia & lymphoma.

Clinical trials targeting advanced cancers by active immunization of T-cell defined tumor antigens.

H. Ikeda, 2003, Current pharmaceutical design.

Brefeldin A Blocks the Cytotoxicity of T Cell Receptor α/β and γ/δ Cytotoxic T Lymphocyte Clones Reacting against Human Autologous Cancer Cells

K. Hirata, Shuji Takahashi, N. Sato, 1993, Japanese journal of cancer research : Gann.

Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)

M. Toyota, K. Houkin, T. Tokino, 2004, Glia.

Histone Deacetylation, But Not Hypermethylation, Modifies Class II Transactivator and MHC Class II Gene Expression in Squamous Cell Carcinomas1

M. Toyota, T. Tokino, N. Sato, 2003, The Journal of Immunology.

Expression in Squamous Cell Carcinomas Transactivator and MHC Class II Gene Hypermethylation, Modifies Class II Histone Deacetylation, But Not

M. Toyota, T. Tokino, N. Sato, 2003 .

Clonal dominance of human autologous cytotoxic T lymphocytes against gastric carcinoma: molecular stability of the CDR3 structure of the TCR alphabeta gene.

K. Hirata, A. Sasaki, N. Sato, 1996, International immunology.

Clonal dominance of human autologous cytotoxic T lymphocytes against gastric carcinoma: molecular stability of the CDR3 structure of the TCRαβ gene

K. Hirata, Shuji Takahashi, A. Sasaki, 1996 .